No Data
No Data
Why Is Summit Therapeutics Stock Trading Higher On Monday?
Merck Germany Buys US Cancer Drugmaker SpringWorks Therapeutics For Around $4 Billion
Today's Analyst Rating | Apple Price Target Raised to $235 by Morgan Stanley, HSBC Cuts Its Price Target Cut on Merck & Co to $100
HSBC Maintains Merck & Co(MRK.US) With Buy Rating, Cuts Target Price to $100
Goldman Sachs: The Q1 performance of U.S. pharmaceutical stocks is reassuring, and the Industry sentiment is slightly becoming more positive.
Goldman Sachs stated that amid cautious sentiment from investors towards the USA pharmaceutical sector before the Earnings Reports season, the performance of USA pharmaceutical companies that have reported results so far for the first quarter has not been worse than expected, and in some cases, it has even exceeded expectations.
Merck's Keytruda Improves Head and Neck Cancer Survival by 34% in Study